• About
  • Blog
  1. Home
  2. Blog
  3. Companies
  4. HUM

Humana Inc.(HUM)

New York Stock Exchange
Sector: Healthcare | Industry: Medical - Healthcare Plans
Humana Inc. logo

Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through three segments: Retail, Group and Specialty, and Healthcare Services. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, and home solutions services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2021, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Latest News & Analysis

Person in business attire examines healthcare data on a tablet in a modern office with purple lighting
Jul 29, 2025

Humana Inc. Prior Authorization Reform and Financial Analysis | Monexa AI

Humana Inc. drives strategic efficiency with prior authorization reforms, impacting costs, provider relations, and financial performance amid healthcare sector shifts.

Read more →
Healthcare professionals in a sleek office reviewing patient data with a subtle purple-themed background
Jul 28, 2025

Humana Inc. Strategic Prior Authorization Overhaul and Financial Performance Analysis | Monexa AI

Humana Inc. initiates a major prior authorization overhaul to cut outpatient approvals by 33% by 2026, aiming to boost efficiency and financial performance amid regulatory challenges.

Read more →
Healthcare professionals reviewing data at a modern clinic with a soft purple background
Jul 28, 2025

Humana Inc. Market Analysis: Earnings Catalysts, Star Ratings Litigation, and Growth Drivers

Comprehensive analysis of Humana's latest earnings drivers, star ratings litigation, Medicare Advantage growth, and strategic diversification impacting its fundamentals.

Read more →
Healthcare investor studying charts on a digital tablet in a modern office with purple lighting
Jul 16, 2025

Humana Inc. Regulatory Challenges and Q2 Earnings Insights | Monexa AI

Explore Humana Inc.'s regulatory risks in Medicare Advantage & Medicaid, recent financial trends, and strategic moves ahead of Q2 earnings.

Read more →
Senior doctor using digital tablet in a modern office with soft purple lighting
Jul 15, 2025

Humana Inc. Q2 2025 Earnings Strategy and Financial Analysis | Monexa AI

In Q2 2025, Humana Inc. focuses on margin over volume in Medicare Advantage and expands CenterWell healthcare services, navigating regulatory and competitive challenges.

Read more →
Female business executive studies financial charts on a tablet in a bright, modern office with purple accents
Jul 14, 2025

Humana Inc. Q2 2025 Earnings & Strategic Update: Margin Focus, Medicare Advantage, and CenterWell Growth

Humana's Q2 2025 report highlights margin expansion, Medicare Advantage membership shifts, CenterWell growth, and strategic cost management amid regulatory pressures.

Read more →
Older adult with glasses looks at a tablet while sitting at a desk with a city view in the background
Jul 10, 2025

Humana Inc. Q2 2025 Analysis: Legal Challenges, Financial Resilience, and Strategic Growth Insights

Explore Humana's Q2 2025 earnings outlook amid DOJ scrutiny, Medicare Advantage dynamics, and CenterWell expansion, with detailed financial and strategic analysis.

Read more →
Modern office building with abstract business icons and legal motifs under ambient purple lighting
Jul 8, 2025

Humana Inc. Legal Challenges and Financial Analysis: Impact on Growth and Market Position

Explore Humana's recent DOJ allegations, securities probes, and Medicare litigation alongside financial metrics shaping its strategic outlook.

Read more →
Corporate office with professionals reviewing financial charts in a modern setting with a purple background
Jul 3, 2025

Humana Inc. Legal Challenges and Strategic Shifts Impacting Financial Outlook - Monexa AI

Humana Inc. faces DOJ kickback allegations, impacting stock and strategy. Explore financials, Medicaid expansion, and competitive dynamics in this detailed update.

Read more →
Mature business person at modern desk with abstract cityscape in purple tones
Jul 2, 2025

Humana Inc. Legal Investigation and Financial Impact Analysis - Monexa AI

Humana Inc. faces a securities investigation amid declining earnings and stock price volatility, impacting its Medicare Advantage growth and investor sentiment.

Read more →
Elderly couple talking to a doctor in a sleek office with soft purple lighting
Jul 1, 2025

Humana Inc. Legal Challenges and Financial Insights: Navigating Medicare Advantage Risks and Market Dynamics

Humana faces DOJ allegations over Medicare Advantage kickbacks amid strong financial metrics, highlighting regulatory risks and strategic imperatives for investors.

Read more →
Business professionals review financial graphs on a modern desk with a soft purple-lit office background
Jun 27, 2025

Humana Faces DOJ Probe: Unpacking Financial Risks and Strategic Shifts

Humana is under intense DOJ scrutiny for alleged Medicare Advantage kickbacks, raising significant questions about its financial health and future strategic direction.

Read more →
Senior healthcare professionals interacting near medical equipment in a modern hospital with a purple-toned ambiance
Jun 16, 2025

Humana (HUM) Financial Analysis: Navigating Regulatory & Growth Shifts

Humana navigates federal investigations and policy reforms while leveraging demographic tailwinds and tech innovations to drive senior care growth.

Read more →
Business executive figurine on reflective surface in a modern office with abstract purple graphs in background
Jun 12, 2025

Humana Inc. (HUM) Analysis: Navigating Legal Headwinds & Strategic Growth

Humana Inc. navigates legal challenges and strategic growth. Discover how DOJ investigations, Medicare Advantage reforms, and data initiatives impact HUM stock and its market position.

Read more →
Illustration: Financial downturn with legal scrutiny. A downward-trending financial graph overshadowed by a gavel, symbolizing a healthcare company's legal challenges and financial impact from Medicare Advantage billing investigations and regulatory scrutiny.
Jun 11, 2025

Humana's Legal Challenges and Financial Resilience in 2025

Humana faces legal probes over billing practices, impacting stock, while financial data shows resilience despite income dip in 2025.

Read more →
HUM stock decline: Analysis of recent market activity and the impact of CMS Medicare Advantage payment rates.
Apr 21, 2025

Humana (HUM) Navigates Rising Costs and Favorable CMS Rate Changes

Humana faces market volatility amid rising costs, strategic shifts, and favorable CMS rate news, impacting its financial trajectory and competitive stance.

Read more →
Humana stock soars after Medicare Advantage rate boost: Analysis of earnings, community health impact, and legal challenges.
Apr 9, 2025

Humana (HUM): Medicare Advantage Boost, Community Health, Legal Risks

Analysis of Humana's Q1 2025 earnings, Medicare Advantage boost, community health impact, legal risks, and financial comparison with UnitedHealth.

Read more →
Humana's strategy for senior healthcare: CenterWell expansion, Icon Health partnership, financial analysis, and stock performance. Stay informed on HUM's initiatives, challenges, and market positioning.
Mar 24, 2025

Humana (HUM): CenterWell Expansion, Icon Health, Financial Analysis

Humana expands CenterWell, partners with Icon Health, and navigates debt offerings amidst rising medical costs. A deep dive into HUM's strategic moves and financial health.

Read more →
Humana's strategic shift towards senior-focused healthcare: CenterWell expansion, Medicare Advantage profitability challenges, and debt offering implications.
Mar 20, 2025

Humana (HUM): Strategic Initiatives in Senior Healthcare and Market Analysis

Humana focuses on senior healthcare via CenterWell and partnerships. Debt offering and rising medical costs impact financials. Community commitment through the Humana Foundation.

Read more →
Humana's strategic initiatives: collaborations, debt management, and rising medical costs analysis.
Mar 17, 2025

Humana Inc. Financial Analysis: Navigating Rising Costs

Humana Inc. faces rising medical costs, particularly in its Medicare Advantage segment, impacting profitability. Strategic initiatives include collaborations and debt management.

Read more →
Humana's Financial Strategy: Analyzing Debt Offering and Medicare Advantage Challenges - Insights for Investors
Mar 6, 2025

Humana's Debt Offering: Implications for Investors and Healthcare

Humana's $1.25B debt offering addresses rising medical costs in its Medicare Advantage segment. Strategic moves include cutting plans, value-based care, and lobbying efforts.

Read more →
Humana's Medicare Advantage challenges and strategies for navigating regulatory hurdles, declining membership, and charting a path forward amidst industry competition.
Mar 3, 2025

Humana's Medicare Advantage Crisis: Navigating Challenges

Analyzing Humana's challenges in the Medicare Advantage market, including declining star ratings, rising medical costs, and strategic responses.

Read more →
Humana (HUM) stock analysis: Navigating Medicare Advantage headwinds, kidney care expansion with Monogram Health, and EPS projections.
Feb 28, 2025

Humana (HUM): Navigating Medicare Advantage Headwinds and Expanding Care Services

Humana Inc. navigates Medicare Advantage challenges, rising costs, and strategic shifts. Expansion of kidney care and community support highlight their path forward.

Read more →
Humana (HUM) Analysis: Strategic shifts in Medicare Advantage, revenue, dividends, and growth. Stay informed on Humana's performance and future outlook.
Feb 27, 2025

Humana (HUM) Analysis: Navigating Medicare Advantage Challenges

Humana Inc. faces Medicare Advantage challenges and rising medical costs. Strategic shifts, including kidney care expansion and dividend payments, aim for long-term growth.

Read more →
Humana's challenges in 2025: Medicare Advantage decline, cost pressures, and strategic responses.
Feb 26, 2025

Humana's Challenges: Medicare Advantage, Costs, and Strategic Responses in 2025

Humana faces Medicare Advantage challenges, rising costs, and CMS star rating pressures. Strategic responses and market positioning are critical. Read the full analysis.

Read more →
Humana's Medicare Advantage challenges: Declining membership, rising costs, and strategic shifts - an in-depth analysis.
Feb 21, 2025

Humana's Medicare Advantage Crisis: Membership Losses & Star Ratings

Humana Inc. faces significant Medicare Advantage challenges, marked by declining memberships and star rating downgrades amid rising healthcare costs.

Read more →
Humana (HUM) company logo on a neutral background.
Feb 18, 2025

Humana's Medicare Advantage Challenges: Strategic Shifts and Market Impact

A comprehensive data-driven analysis of Humana’s Q4 2024 performance, membership decline, CMS star ratings, and strategic market shifts.

Read more →

Professional-grade financial analysis tools for informed investment decisions.

Product

  • Features
  • Pricing

Resources

  • Blog
  • Knowledge Base
  • Community
  • Market Data

Company

  • About
  • Careers
  • Contact
  • Partners

Legal

  • Privacy
  • Terms
  • License
  • Security

© 2025 Monexa. All rights reserved. Market data provided by financial exchanges and may be delayed as specified by financial exchanges or our data providers.